Designing studies to evaluate anti-hepatitis B virus therapies: from the perspective of studies for the registration of pharmaceutical products.
Murray
Alison B
AB
Roche Molecular Systems, Oakland, CA, USA.
D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004341:Drug Evaluation; D006509:Hepatitis B / Q000188:drug therapy* / Q000201:enzymology / Q000821:virology; D006801:Humans; D008099:Liver / Q000473:pathology; D019562:Viral Load
D000998:Antiviral Agents; D000410:Alanine Transaminase